|
|
||||||||
J Thorac Cardiovasc Surg 1999;117:1095-1101
© 1999 Mosby, Inc.
GENERAL THORACIC SURGERY |
From the Department of Thoracic Surgery, Marie Lannelongue Hospital, Le Plessis Robinson, France.
Received for publication Nov 4, 1998. Revisions requested Jan 12, 1999. Revisions received Feb 15, 1999. Accepted for publication Feb 19, 1999. Address for reprints: J. F. Regnard, MD, Service de Chirurgie Thoracique et Vasculaire, Centre Chirurgical Marie Lannelongue, 133 avenue de la résistance, Le Plessis Robinson, 92350 France.
Objective: Because completion pneumonectomy is a procedure reputed to place patients at risk, we reviewed our results with the objective of identifying factors that influence complications and survival.
Methods: In a 25-year period, 80 completion pneumonectomies were performed after first operations for 17 cases of benign disease and 63 cases of lung cancer (89% stages I and II), with 7 of the latter patients receiving postoperative radiotherapy. Completion pneumonectomy was performed in 18 cases of benign disease and 62 cases of lung cancer: 28 second primary cancers, 26 recurrent cancers, 3 metastases, and 5 primary cancers in patients previously operated on for benign disease.
Results: No intraoperative deaths occurred. Postoperative mortality rates were 5% for the entire series, 6.4% for patients operated on for cancer, and 0% for patients operated on for benign diseases. Patients previously irradiated and those operated on for infectious disease were at risk for postoperative empyema and fistula formation. In the cancer treatment group the actuarial 5-year survival was 36%, without significant difference between patients with recurrent and second primary lung cancers. The actuarial 5-year survivals were 51% for patients with stage I disease, 42% for patients with stage II disease, and 18% for patients with stage IIIA disease (P < .05).
Conclusions: Completion pneumonectomy can be performed with an acceptable operative mortality rate and offers a second chance for cure to patients with cancer. Patients previously irradiated and those requiring completion pneumonectomy for infectious benign disease are at risk for postoperative complications. (J Thorac Cardiovasc Surg 1999;117:1095-101)
This article has been cited by other articles:
![]() |
O. Chataigner, E. Fadel, B. Yildizeli, A. Achir, S. Mussot, D. Fabre, O. Mercier, and P. G. Dartevelle Factors affecting early and long-term outcomes after completion pneumonectomy Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 837 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Guggino, C. Doddoli, F. Barlesi, P. Acri, B. Chetaille, P. Thomas, R. Giudicelli, and P. Fuentes Completion pneumonectomy in cancer patients: experience with 55 cases Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 449 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Miller, C. Deschamps, G. D. Jenkins, A. Bernard, M. S. Allen, and P. C. Pairolero Completion pneumonectomy: factors affecting operative mortality and cardiopulmonary morbidity Ann. Thorac. Surg., September 1, 2002; 74(3): 876 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujimoto, G. Zaboura, S. Fechner, L. Hillejan, T. Schroder, A. Marra, T. Krbek, M. Hinterthaner, D. Greschuchna, and G. Stamatis Completion pneumonectomy: Current indications, complications, and results J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 484 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sonobe, M. Nakagawa, M. Ichinose, N. Ikegami, M. Nagasawa, and T. Shindo Analysis of risk factors in bronchopleural fistula after pulmonary resection for primary lung cancer Eur. J. Cardiothorac. Surg., November 1, 2000; 18(5): 519 - 523. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |